Supplemental information for PAR-16-357
Office of the Director
Program Announcements
- Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) PAR-20-097
- NIDA Program Project Grant Applications (P01 Clinical Trial Optional) PAR-19-345
Request for Applications
- Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) RFA-OD-21-003
- Tobacco Regulatory Science (R01 Clinical Trial Optional) RFA-OD-21-002
Notices of Special Interest (NOSI)
Notices
Chemistry Pharmacology Branch
Notices of Special Interest (NOSI)
- Notice of Special Interest (NOSI): Research in the Chemistry and Pharmacology of Addictive Drugs NOT-DA-23-002 - R03,R21,R01,K99/R00,R36,K01
- Notice of Special Interest (NOSI): Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects NOT-DA-21-028 - R01,R21,R03
- Notice of Special Interest (NOSI): Basic Research on Fentanyl and Synthetic Fentanyl Analogs: Signaling, Neurobiology, and Pharmacology NOT-DA-21-033 - R01,R21
Notices
- Notice of Participation in PAR-18-721 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed) NOT-NS-18-053
- Notice of Interest to Highlight NIDA High-Priority Workforce Development Needs in the Chemistry of Addiction NOT-DA-17-063
Genetics, Epigenetics and Development Branch
Program Announcements
- NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) PAR-20-267
- Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) PAR-20-225
- Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional) PAR-20-224
- NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) PAR-20-221
- Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) PAR-20-147
- Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) PAR-20-148
Request for Applications
Notices of Special Interest (NOSI)
- Notice of Special Interest (NOSI): Advancing Research on SUD through Computational Neuroscience NOT-DA-20-022 - R01,R21
- Notice of Special Interest (NOSI): Exploring the Roles of Biomolecular Condensates (BMCs) in Substance Use Disorder and/or HIV-related processes NOT-DA-20-018 - R01,R03,R21,333
- Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain NOT-DA-20-039 - R01,R03,R21
- Notice of Special Interest (NOSI): Human Molecular Genetics of Substance Use Disorders NOT-DA-20-030 - R01,P50,P01
- Notice of Special Interest (NOSI): Transcriptomic, epigenomic, regulatory RNA or functional genomic research in Substance Use Disorders NOT-DA-20-031 - R01,R03,R21,333,R21/R33
- Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics NOT-DA-20-009 - R01,R03,R21
Notices
Behavioral Cognitive Neuroscience Branch
Program Announcements
- Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) PAR-21-349
- Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional) PAR-21-310
- Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) PAR-21-281
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) PAR-19-282
Request for Applications
- Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) RFA-OD-21-003
- Tobacco Regulatory Science (R01 Clinical Trial Optional) RFA-OD-21-002
Notices of Special Interest (NOSI)
- Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects NOT-OD-21-127 - 333,R03,R01,R21
- Notice of Special Interest (NOSI): Advancing HIV/AIDS Research through Computational Neuroscience NOT-DA-21-030 - R01,R21,R03,DP2,DP1,K99/R00,K01,R36,P01,R15,K24
- Notice of Special Interest (NOSI): Leveraging Longitudinal Studies in Animal Models to Identify Neural Mechanisms of Vulnerability and Resilience to Substance Use Disorder NOT-DA-21-003 - R01,R21,R15,R03
- Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease NOT-AT-21-002 - R01,R21
- Notice of Special Interest (NOSI): Advancing Research on SUD through Computational Neuroscience NOT-DA-20-022 - R01,R21
- Notice of Special Interest (NOSI): Harnessing computational tools for sophisticated analyses of Substance Use Disorder-related behaviors NOT-DA-20-017 - R01,R03,R21,333
- Notice of Special Interest (NOSI): Mentored Career Development Award in Large-Scale Clinical Study Development and Analysis NOT-DA-20-006 - K08,K23,K25,K01,K99/R00
- Notice of Special Interest (NOSI): Mechanistic Investigations of Psychosocial Factors Associated with Substance Use Disorders NOT-DA-20-005 - R01,R21
Notices
- Notice of Intent to Publish a Funding Opportunity Announcement for the NIH Blueprint Training in Computational Neuroscience (T90/R90) NOT-DA-21-085
- Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) NOT-DA-21-081
- Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) NOT-DA-21-082
Integrative Neuroscience Branch
Notices
- BRAIN Initiative: Notice of Support for Research on the Fundamental Neurobiology of Endogenous Opioid Systems NOT-DA-18-046
- Notice of Change to the Open Date in PA-18-917, " Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional) NOT-DA-18-044
- Notice of Change to the Eligibility of Foreign Components in PA-18-060, " Neuroscience Research on Drug Abuse (R01)" NOT-DA-18-042
- Notice of Change to the Eligibility of Foreign Components in PA-18-078, " Neuroscience Research on Drug Abuse (R21)" NOT-DA-18-043